Professor Lina Badimón, head of the group of Molecular and Therapeutic Pathology of Atherothrombotic and Ischemic Diseases of the Research Institute of the Hospital de la Santa Creu i Sant Pau – IIB Sant Pau, has joined the Royal Academy of Medicine of Catalonia (RAMC) as a Numerary Academician.
Her admission ceremony was held on Sunday, May 16th , 2021, in an extraordinary public session at the headquarters of the Royal Academy of Medicine of Catalonia, in which Dr. Badimon read the speech “Precision Medicine in Cardiology”. Dr. Badimon is attached to the first section in basic, diagnostic and therapeutic sciences and entered t
o receive the 48 medal, that Dr. Soledat Woessner i Casas had previously held, now Emeritus Academic, who together with Dr. Miquel Vilardell i Tarrés acted as godparents. The answer to her speech on behalf of the Academy was in charge of the numerary academic, Dr. Antoni Bayés de Luna.
In her entrance speech, Dr. Badimon presented the so-called Precision Medicine and explained, how this new approach to medicine that relies on science – omics and data (big data) as its main support – will shape clinical practice of the future. Not only did she take a tour of this discipline and present the main benefits and challenges, but she also contextualized this type of medicine in the field of cardiovascular diseases, an area in which she is an internationally renowned expert. She showed through examples how precision medicine can contemplate many variables to the same problem, and how the integration of all these data can result in a better characterization of patients, in better defined clinical trials and in responses that allow us to offer personalized prevention tools and treatments.
As Dr. Badimon pointed out, the challenge now is to incorporate this into clinical practice.
The session and the speech of Dr. Badimon are available on the RAMC YouTube channel, at this link.
Lina Badimon Maestro, directs the research group of Molecular and Therapeutic Pathology of Atherothrombotic and Ischemic diseases. She is a research professor at the Higher Council for Scientific Research and Director of the Chair for Cardiovascular Research at the UAB, and the UNESCO Chair for biomedicine, Deputy Lecturer Associate Professor of Medicine – Cardiology – at the Mount Sinai School of Medicine, New York and Visiting Professor at Manchester Metropolitan University, UK and Paris-Est University, France.
Her career includes posts and positions of responsibility at the former Institute of Cardiovascular Sciences, the CSIC, the Massachusetts General Hospital in Boston, the Harvard Medical School in Boston, and the Mount Sinai School of Medicine in New York. She has been President of the Spanish Society of Arteriosclerosis, President of the European Society for Clinical Investigation, Vice President of the Spanish Society of Cardiology (SEC) and of the European Society of Cardiology (ESC), Chair of the Council on Basic Science of the ESC and of various working groups in both organizations.
Currently, she is a member of the Board of the European Society of Cardiology, Chair of the Patient Forum and Women @ ESC. She is also the President of the European Mediterranean League Against Thromboembolic Diseases Foundation (EMLTDF).
